137 related articles for article (PubMed ID: 2622972)
21. Effects of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on cardiac function in perfused guinea-pig heart.
Saeki S; Masugi F; Ogihara T; Otsuka A; Kumahara Y; Watanabe K; Tamura K; Akashi A; Kumagai A
Life Sci; 1985 Jul; 37(4):325-9. PubMed ID: 4010479
[TBL] [Abstract][Full Text] [Related]
22. Effects of platelet-activating factor on beta- and H2-receptor-mediated increase of myocardial contractile force in isolated perfused guinea pig hearts.
Felix SB; Baumann G; Niemczyk M; Ahmad Z; Hashemi T; Berdel WE
Res Exp Med (Berl); 1991; 191(1):1-9. PubMed ID: 1852056
[TBL] [Abstract][Full Text] [Related]
23. BN-52021 protects guinea-pig from heart anaphylaxis.
Magni F; Rossoni G; Berti F
Pharmacol Res Commun; 1988 Dec; 20 Suppl 5():75-8. PubMed ID: 3247358
[TBL] [Abstract][Full Text] [Related]
24. Possible involvement of platelet activating factor in anaphylaxis of passively sensitised, isolated guinea pig hearts.
Tosaki A; Koltai M; Braquet P; Szekeres L
Cardiovasc Res; 1989 Aug; 23(8):715-22. PubMed ID: 2557156
[TBL] [Abstract][Full Text] [Related]
25. PAF-acether induced cardiac dysfunction in the isolated perfused guinea pig heart.
Stahl GL; Lefer DJ; Lefer AM
Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):459-63. PubMed ID: 3431598
[TBL] [Abstract][Full Text] [Related]
26. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig.
Desquand S; Touvay C; Randon J; Lagente V; Vilain B; Maridonneau-Parini I; Etienne A; Lefort J; Braquet P; Vargaftig BB
Eur J Pharmacol; 1986 Aug; 127(1-2):83-95. PubMed ID: 3019727
[TBL] [Abstract][Full Text] [Related]
27. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig.
Lagente V; Touvay C; Randon J; Desquand S; Cirino M; Vilain B; Lefort J; Braquet P; Vargaftig BB
Prostaglandins; 1987 Feb; 33(2):265-74. PubMed ID: 2438723
[TBL] [Abstract][Full Text] [Related]
28. Antagonism of platelet activating factor-induced chemiluminescence in guinea-pig peritoneal macrophages in differing states of activation.
Parnham MJ; Bittner C; Lambrecht G
Br J Pharmacol; 1989 Oct; 98(2):574-80. PubMed ID: 2819335
[TBL] [Abstract][Full Text] [Related]
29. Endothelium-dependent effects of platelet-activating factor in the coronary circulation.
Sagach VF; Zhukova AV; Braquet P
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S85-9. PubMed ID: 1282996
[TBL] [Abstract][Full Text] [Related]
30. Cardiac ultrastructural effects of the platelet-activating factor and its antagonist BN 52021.
Kecskeméti V; Balogh I
Exp Toxicol Pathol; 1995 Dec; 47(6):463-70. PubMed ID: 8871085
[TBL] [Abstract][Full Text] [Related]
31. The effect of the specific PAF antagonist BN 52021 and the calcium blocker diltiazem on PAF induced arrhythmogenicity.
Riedel A; Braquet P; Mest HJ
Pharmacol Res Commun; 1987 Oct; 19(10):703-12. PubMed ID: 3441484
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of a novel platelet activating factor (PAF) antagonist (BN 52021) on antigen-induced prostaglandin and thromboxane formation by the guinea pig lung.
Harczy M; Maclouf J; Pradelles P; Braquet P; Borgeat P; Sirois P
Pharmacol Res Commun; 1986 Aug; 18 Suppl():111-7. PubMed ID: 3095849
[TBL] [Abstract][Full Text] [Related]
33. Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model.
Cruzado JM; Torras J; Riera M; Lloberas N; Herrero I; Condom E; Martorell J; Alsina J; Grinyó JM
Clin Exp Immunol; 1998 Jul; 113(1):136-44. PubMed ID: 9697996
[TBL] [Abstract][Full Text] [Related]
34. [Experimental study on antagonism of ginkgolides against effect of platelet-activating factor on lung strip of guinea pigs].
Dong JC; Li M; Wu GT
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Aug; 17(8):481-3, 502. PubMed ID: 10322836
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
[TBL] [Abstract][Full Text] [Related]
36. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM
J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292
[TBL] [Abstract][Full Text] [Related]
37. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
Coëffier E; Joseph D; Vargaftig BB
J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the coronary vascular responses to platelet-activating factor in the isolated perfused heart.
Hu WM; Choy PC; Man RY
Lipids; 1991 Sep; 26(9):700-4. PubMed ID: 1762514
[TBL] [Abstract][Full Text] [Related]
39. Release of cysteinyl-leukotrienes is of minor importance in PAF induced reduction of perfusion rate in the gastric vascular bed.
Dembińska-Kieć A; Peskar BM; Peskar BA
Biomed Biochim Acta; 1988; 47(10-11):S228-32. PubMed ID: 3248109
[TBL] [Abstract][Full Text] [Related]
40. [Ginkgolides antagonizing some effects of platelet-activating factor in vitro].
Dong JC; Li M; Shi ZY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Oct; 15(10):606-8. PubMed ID: 8704427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
